Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC

PHASE1UnknownINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

September 25, 2017

Primary Completion Date

October 31, 2022

Study Completion Date

February 28, 2023

Conditions
Melanoma (Skin)Squamous Cell Carcinoma of the SkinCarcinoma, Squamous Cell of Head and NeckCarcinoma, Adenoid Cystic
Interventions
BIOLOGICAL

CV8102

CV8102 alone

BIOLOGICAL

CV8102 + anti-PD-1 therapy

CV8102 in combination with standard of care anti-PD-1 therapy

Trial Locations (22)

Unknown

Medical University of Graz, Graz

Universitätsklinik für Dermatologie der Paracelsus medizinischen Privatuniversität Salzburg, Salzburg

Hôpital Saint Louis, Paris

Institut Gustave Roussy, Paris

Charité Benjamin Franklin, Berlin

Medizinische Klinik III, Universitätsklinikum Bonn, Hämatologie, Immunonkologie und Rheumatologie, Bonn

Elbe-Klinikum-Buxtehude, Hautkrebszentrum, Buxtehude

Universitätsklinikum Erlangen,Hautklinik, Internistisches Zentrum (INZ), Erlangen

Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg, Heidelberg

Universitätsklinikum Schleswig-Holstein, Klinik für Dermatologie, Allergologie und Venerologie, Lübeck

Fachklinik Hornheide, Münster

Universitätsklinikum Münster, Klinik für Hautkrankheiten, ZiD- Zentrum für innovative Dermatologie, Münster

Universitäts-Hautklinik, Abtl. Dermatologische Onkologie, Tübingen

Center for Personalized Oncology, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moscow

"FSBI National Medical Research Center of Oncology n.a. N.N. Blokhin of the Ministry of Healthcare of the Russian Federation", Moscow

"FSBI National Medical Research Oncology Center n.a. N.N. Petrov", Saint Petersburg

Saint-Petersburg State University, Clinic of advanced medical technologies n. a. Nicolay I. Pirogov., Saint Petersburg

Hospital Duran i Reynals - Institut Catala dOncologia ICO, Barcelona

Hospital Universitari Vall d'Hebron, Barcelona

Hospital Ramon y Cajal, Madrid

Hospital Universitario Virgen de la Victoria, Málaga

Hospital Universitario Marqus de Valdecilla Santander, Santander

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Syneos Health

OTHER

collaborator

Cromos Pharma LLC

INDUSTRY

lead

CureVac

INDUSTRY